Synlett 2009(8): 1261-1264  
DOI: 10.1055/s-0029-1216731
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

The Synthesis of AraBOX, a New 4,4′-Bis(oxazoline), from Novel Pentitol-Derived Bis-β-amino Alcohols

David Fraina, Fiona Kirbya, Patrick McArdleb, Patrick O’Leary*a
a School of Chemistry, SMACT (Synthetic Methods: Asymmetric Catalytic Transformations), National University of Ireland, Galway, Ireland
Fax: +353(91)525700; e-Mail: patrick.oleary@nuigalway.ie;
b School of Chemistry, National University of Ireland, Galway, Ireland
Weitere Informationen

Publikationsverlauf

Received 5 February 2009
Publikationsdatum:
17. April 2009 (online)

Abstract

The preparation of a novel phenyl 4,4′-bis(oxazoline) [AraBOX] is described. The novel ligand is prepared in two efficient steps from a bis-[(O-silyl)β-amino alcohol], via conversion into an intermediate bis(benzamide) followed by a one-pot deprotection-activation-ring closure (DARC) oxazoline formation. To our knowledge, this is the first reported synthesis of an oxazoline ring via this DARC method. The synthesis of two precursor bis-β-amino alcohols, (2R,4R)- and meso-2,4-diaminopentane-1,5-diol, derived from d-(+)-arabitol and xylitol, respectively, is also described.

    References and Notes

  • 1a Guiry PJ. Saunders CP. Adv. Synth. Catal.  2004,  346:  497 
  • 1b McManus HA. Guiry PJ. Chem. Rev.  2004,  104:  4151 
  • 1c Goudriaan PE. van Leeuwen PWNM. Birkholtz M.-N. Reek JNH. Eur. J. Inorg. Chem.  2008,  2939 
  • 2a Christoffers J. Koripelly G. Rosiak A. Rossle M. Synthesis  2007,  1279 
  • 2b Trost BM. Jiang CH. Synthesis  2006,  369 
  • 3 Li YM. Kwong FY. Yu WY. Chan ASC. Coord. Chem. Rev.  2007,  251:  2119 
  • 4a Taylor MS. Zalatan DN. Lerchner AM. Jacobsen EN. J. Am. Chem. Soc.  2005,  127:  1313 
  • 4b Egami H. Katsuki T. Angew. Chem. Int. Ed.  2008,  47:  5171 
  • 4c Achard TRJ. Clutterbuck LA. North M. Synlett  2005,  1828 
  • 5 Brunel JM. Chem. Rev.  2007,  107:  PR1 
  • 6a Palomo C. Oiarbide M. Laso A. Eur. J. Org. Chem.  2007,  16:  2561 
  • 6b Evans DA. Woerpel KA. Hinman MM. Faul MM. J. Am. Chem. Soc.  1991,  113:  726 
  • 6c Corey EJ. Imai N. Zhang HY. J. Am. Chem. Soc.  1991,  113:  728 
  • 6d Desimoni G. Faita G. Jørgensen KA. Chem. Rev.  2006,  106:  3561 
  • Kato T. Marubayashi K. Takizawa S. Sasai H. Tetrahedron: Asymmetry  2004,  3693 
  • 7a McDonagh C. O’Leary P. Tetrahedron Lett.  2009,  50:  979 
  • 7b McDonagh C. O’Conghaile P. Klein Gebbink RJM. O’Leary P. Tetrahedron Lett.  2007,  48:  4387 
  • 7c Bateman L. Breeden SW. O’Leary P. Tetrahedron: Asymmetry  2008,  19:  391 
  • 8 Pellissier H. Tetrahedron  2008,  64:  7041 
  • 9a Denmark SE. Nakajima N. Nicaise OJC. Faucher AM. Edwards JP. J. Org. Chem.  1995,  60:  4884 
  • 9b Wipf P. Venkatraman S. Tetrahedron Lett.  1996,  37:  4659 
  • 9c Evans DA. Woerpel KA. Scott MJ. Angew. Chem., Int. Ed. Engl.  1992,  31:  430 
  • 9d Davies IW. Senanayake CH. Larsen RD. Verhoeven TR. Reider PJ. Tetrahedron Lett.  1996,  37:  813 
  • 9e Cornejo A. Fraile JM. Garcia JI. Gil MJ. Martinez-Merino V. Mayoral JA. Pires E. Villalba I. Synlett  2005,  2321 
  • 10a Szakonyi Z. Hetényi A. Fülöp F. Tetrahedron  2008,  64:  1034 
  • 10b Pedrosa R. Andrés C. Mendiguchía P.
    J. Org. Chem.  2006,  71:  8854 
  • 10c Steiner D. Sethofer SD. Goralski CT. Singaram B. Tetrahedron: Asymmetry  2002,  13:  1477 
  • 11a Kempf DJ. Sowin TJ. Doherty EM. Hannick SM. Codavoci L. Henry RF. Green BE. Spanton SG. Norbeck DW. J. Org. Chem.  1992,  57:  5692 
  • 11b Alcon M. Poch M. Moyano A. Pericas MA. Riera A. Tetrahedron: Asymmetry  1997,  8:  2967 
  • 11c Beaulieu PL. Gillard J. Bailey M. Beaulieu C. Duceppe J. Lavallée P. Wernic D. J. Org. Chem.  1999,  64:  6622 
  • 12a Roger EW. Molinski TF. J. Org. Chem.  2007,  9:  437 
  • 12b Mishra RK. Coates CM. Revell KD. Turos E. Org. Lett.  2007,  9:  575 
  • 13a Taylor SM. Yamada T. Ueki H. Soloshonok VA. Tetrahedron Lett.  2004,  45:  9159 
  • 13b Soloshonok VA. Yamada T. Ueki H. Moore AM. Cook TK. Arbogast KL. Soloshonok AV. Martin CH. Ohfune Y. Tetrahedron  2006,  62:  6412 
  • 14a Boydell AJ. Jeffery MJ. Burkstummer E. Linclau B. J. Org. Chem.  2003,  68:  8252 
  • 14b Linclau B. Boydell AJ. Clarke PJ. Horan R. Jacquet C. J. Org. Chem.  2003,  68:  1821 
  • 17 Gembus V. Marsais F. Levacher V. Synlett  2008,  1463 
15

(2 R ,4 R )-2,4-Diaminopentane-1,5-diol Dihydrochloride (11)
¹H NMR (400 MHz, D2O): δ = 3.86 (2 H, dd, J = 12.4, 3.7 Hz 2 × one of CH 2OH), 3.71 (2 H, dd, J = 12.4, 6.0 Hz, 2 × one of CH 2OH), 3.56-3.50 (2 H, m, 2 × CHNH2), 2.05 (2 H, t, J = 7.1 Hz, CHCH 2 CH). ¹³C NMR (100 MHz, CDCl3): δ = 60.2 (2 × CH2OH), 49.4 (2 × CHN), 28.8 (CHCH2CH) ppm. IR: 3512, 3333, 3048 (br), 2907, 1490, 1036 cm. Anal. Calcd for C5H16Cl2N2O2: C, 29.00; H, 7.79; N, 13.53. Found C, 29.17; H, 7.63; N, 13.71. [α]D ²² -46.5 (c 0.7, MeOH). The CIF file for this compound has been deposited with the The Cambridge Crystallographic Data Centre (deposition number 719095).

16

meso -2,4-Diaminopentane-1,5-diol Dihydrochloride (12)
¹H NMR (400 MHz, D2O): δ = 3.84 (2 H, dd, J = 12.4, 3.7 Hz 2 × one of CH 2OH), 3.67 (2 H, dd, J = 12.6, 6.0 Hz, 2 × one of CH 2OH), 3.52-3.47 (2 H, m, 2 × CHNH2), 2.08-1.88 (2 H m, CHCH 2CH). ¹³C NMR (100 MHz, CDCl3): δ = 60.5 (2 × CH2OH), 49.2 (2 × CHN), 28.9 (CHCH2CH). IR: 3315 (br), 2927 (br), 1612, 1559, 1513 cm. Anal. Calcd for C5H16Cl2N2O2: C, 29.00; H, 7.79; N, 13.53. Found C, 28.37; H, 7.3; N, 12.53. The CIF file for this compound has been deposited with the The Cambridge Crystallographic Data Centre (deposition number 719096).

18

N , N ′-[(2 R ,4 R )-1,5-Bis{[ tert -butyl(dimethyl)silyl]oxy}-pentane-2,4-diyl]benzamide (13)
¹H NMR (400 MHz, CDCl3): δ = 7.77 (4 H, d, J = 6.9 Hz, 4 × ortho ArH), 7.48-7.35 (6 H, m, 4 × meta ArH, 2 × para ArH), 7.05 (2 H, d, J = 7.8 Hz, 2 × NH), 4.19-4.12 (2 H, m, 2 × CHN), 3.88-3.81 (4 H, m, 2 × CH2O), 2.07 (2 H, t, J = 6 Hz, CHCH 2 CH). ¹³C NMR (100 MHz, CDCl3): δ = 167.5 (2 × HNC=O), 134.5 (2 × ArCC=O), 131.5 (2 × para ArC), 128.6 (4 × ortho ArC), 127.0 (4 × meta ArC), 64.9 (2 × CH2OSi), 49.2 (2 × CHNH2), 33.4 (CHCH2CH), 26.0 (6 × CH3), 18.3 (2 × C), -5.3 [2 × Si(CH3)2]. IR: 3279, 2928, 1629, 1536, 1102, 777, 691 cm. Anal. Calcd for C31H50N2O4Si2: C, 65.25; H, 8.83; N, 4.91. Found: C, 65.25; H, 8.74; N, 4.77. [α]D ²² +52.2 (c 0.9, MeCN).

19

To a solution of 13 (300 mg, 0.525 mmol) and TsF (140mg, 1.155 mmol) in dry MeCN (5 mL) was added DBU (185 µL, 1.115 mmol). The mixture was stirred at reflux overnight, cooled, and concentrated in vacuo. The residue was purified by flash chromatography on SiO2 (PE-EtOAc, 80:20) to yield desired bis(oxazoline) 1 (120 mg, 75%).
4,4′-Methylenebis[(4 R )-2-phenyl-2-oxazoline] (1)
¹H NMR (400 MHz, CDCl3): δ = 7.95 (4 H, d, J = 6.9 Hz, 4 × ortho ArH), 7.49-7.38 (6 H, m, 4 × meta ArH, 2 × para ArH), 4.66 (2 H, app t, J = 8.5 Hz, 2 × one of CH2O), 4.61-4.51 (2 H, m, 2 × CHN), 4.14 (2 H, app t, J = 8 Hz, 2 × one of CH2O), 1.98 (2 H, t, J = 7 Hz, CHCH 2CH). ¹³C NMR (100 MHz, CDCl3): δ = 163.9 (2 × C=N), 131.4 (2 × para ArC), 128.4 (4 × ortho ArC), 128.3 (4 × meta ArC), 127.9 (2 × ArCCN), 73.7 (2 × CHO), 65.5 (2 × CHN), 43.3 (CHCH2CH). IR: 2924, 1720, 1642, 1080, 1025, 779, 688 cm. Anal. Calcd for C19H18N2O2: C, 74.49; H, 5.92; N, 9.14. Found: C, 74.15; H, 5.83; N, 8.75. [α]D ²³ +57.1 (c 0.7, MeCN). The CIF file for this compound has been deposited with the The Cambridge Crystallographic Data Centre (deposition number 719094).